Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Grégory Mougel"'
Autor:
Arnaud Lagarde, Grégory Mougel, Lucie Coppin, Magalie Haissaguerre, Lauriane Le Collen, Amira Mohamed, Marc Klein, Marie-Françoise Odou, Antoine Tabarin, Hedia Brixi, Thomas Cuny, Brigitte Delemer, Anne Barlier, Pauline Romanet
Publikováno v:
Endocrine Connections, Vol 11, Iss 11, Pp 1-8 (2022)
Purpose: Mosaicism is a feature of several inherited tumor syndromes. Only a few cases of mosaicism have been described in multiple endocrine neoplasia type 1 (MEN1). Next-generation sequencing (NGS) offers new possibilities for detecti ng mosaicism.
Externí odkaz:
https://doaj.org/article/950beb9810fc45259d37eaf1892dd502
Autor:
Arnaud Lagarde, Lauriane Le Collen, Camille Boulagnon, Hedia Brixi, Anne Durlach, Grégory Mougel, Thomas Cuny, Brigitte Delemer, Anne Barlier, Pauline Romanet
Publikováno v:
Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, 2022, 107 (10), pp.e4154-e4158. ⟨10.1210/clinem/dgac454⟩
Journal of Clinical Endocrinology and Metabolism, 2022, 107 (10), pp.e4154-e4158. ⟨10.1210/clinem/dgac454⟩
Context Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease caused by inactivating mutations in the MEN1 gene. In the literature, few cases of MEN1 have been reported because of mosaic MEN1 mutations. Objective We performed an
Autor:
Lucie Coppin, Sophie Giraud, Eric Pasmant, Arnaud Lagarde, Marie-Odile North, Lauriane Le-Collen, Valérie Aubert, Grégory Mougel, Miriam Ladsous, Alyzée Louboutin, Hedia Brixi, Magalie Haissaguerre, Nicolas Scheyer, Marc Klein, Antoine Tabarin, Brigitte Delemer, Anne Barlier, Marie-Françoise Odou, Pauline Romanet
Publikováno v:
European Journal of Endocrinology
European Journal of Endocrinology, 2023, 187 (1), pp.K1-K6. ⟨10.1530/EJE-22-0171⟩
European Journal of Endocrinology, 2023, 187 (1), pp.K1-K6. ⟨10.1530/EJE-22-0171⟩
MEN1 is an autosomal dominant hereditary syndrome characterized by several endocrine tumors, in most cases affecting the parathyroid glands, pancreas, and anterior pituitary. It is the result of inactivating mutations in the tumor suppressor gene MEN
Autor:
Catherine Roche, Guillaume Assié, Justine Galluso, Grégory Mougel, Henry Dufour, Pauline Romanet, Thomas Cuny, Mirella Hage, Dominique Figarella-Branger, Daniel De Murat, Heather C. Etchevers, Marily Theodoropoulou, Peter Kamenicky, Anne Barlier, Thomas Graillon
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 14
International Journal of Molecular Sciences, MDPI, 2021, 22 (14), pp.7570. ⟨10.3390/ijms22147570⟩
International Journal of Molecular Sciences, 2021, 22 (14), pp.7570. ⟨10.3390/ijms22147570⟩
International Journal of Molecular Sciences, Vol 22, Iss 7570, p 7570 (2021)
Volume 22
Issue 14
International Journal of Molecular Sciences, MDPI, 2021, 22 (14), pp.7570. ⟨10.3390/ijms22147570⟩
International Journal of Molecular Sciences, 2021, 22 (14), pp.7570. ⟨10.3390/ijms22147570⟩
International Journal of Molecular Sciences, Vol 22, Iss 7570, p 7570 (2021)
Background: Forty percent of somatotroph tumors harbor recurrent activating GNAS mutations, historically called the gsp oncogene. In gsp-negative somatotroph tumors, GNAS expression itself is highly variable
those with GNAS overexpression most r
those with GNAS overexpression most r
Autor:
Pauline, Romanet, Justine, Galluso, Peter, Kamenicky, Mirella, Hage, Marily, Theodoropoulou, Catherine, Roche, Thomas, Graillon, Heather C, Etchevers, Daniel, De Murat, Grégory, Mougel, Dominique, Figarella-Branger, Henry, Dufour, Thomas, Cuny, Guillaume, Assié, Anne, Barlier
Publikováno v:
International Journal of Molecular Sciences
Forty percent of somatotroph tumors harbor recurrent activating GNAS mutations, historically called the gsp oncogene. In gsp-negative somatotroph tumors, GNAS expression itself is highly variable; those with GNAS overexpression most resemble phenotyp
Autor:
Dominique Figarella-Branger, Matthieu Peyre, Michel Kalamarides, Hadrien Peyrière, Didier Autran, Emeline Tabouret, Jason Siffre, Marc Sanson, Grégory Mougel, Anne Barlier, Thierry Colin, Olivier Chinot, Loic Ferrer, Henry Dufour, Thomas Graillon
Publikováno v:
Neuro Oncol
Neuro-Oncology
Neuro-Oncology, Oxford University Press (OUP), 2021, 13 (6), pp.1294. ⟨10.1093/neuonc/noab019⟩
Neuro-Oncology, 2021, 13 (6), pp.1294. ⟨10.1093/neuonc/noab019⟩
Neuro-Oncology
Neuro-Oncology, Oxford University Press (OUP), 2021, 13 (6), pp.1294. ⟨10.1093/neuonc/noab019⟩
Neuro-Oncology, 2021, 13 (6), pp.1294. ⟨10.1093/neuonc/noab019⟩
Background We aimed to improve the assessment of the drug activity in meningioma clinical trials based on the study of the 3D volume growth rate (3DVGR) in a series of aggressive meningiomas. We secondarily aimed to correlate 3DVGR study with patient
Autor:
Henry Dufour, Heather A. Halem, Michael D. Culler, Shengwen Zhang, Alexandru Saveanu, Thomas Graillon, Anne Barlier, Célines Defilles, Rakesh Datta, Grégory Mougel, Thierry Brue, Tanya Landsman, Thomas Cuny, Dominique Figarella-Branger
Publikováno v:
Pituitary
Pituitary, 2021, 24 (3), pp.351-358. ⟨10.1007/s11102-020-01113-4⟩
Pituitary, Springer Verlag, 2021, 24 (3), pp.351-358. ⟨10.1007/s11102-020-01113-4⟩
Pituitary, 2021, 24 (3), pp.351-358. ⟨10.1007/s11102-020-01113-4⟩
Pituitary, Springer Verlag, 2021, 24 (3), pp.351-358. ⟨10.1007/s11102-020-01113-4⟩
Somatostatin (SST) and dopamine (DA) inhibit growth hormone (GH) secretion and proliferation of GH-secreting pituitary adenomas (GHomas) through binding to SSTR2 and D2R receptors. Chimeric SST-DA compounds (Dopastatins) display increased potency in
Autor:
Thierry Brue, Frédérique Albarel, Thomas Cuny, Grégory Mougel, C. Mouly, Alexandru Saveanu, Frederic Castinetti, Pauline Romanet, Wassim Essamet, Arnaud Lagarde, Perrine Luigi, Anne Barlier, Magaly Vialon
Publikováno v:
European Journal of Endocrinology
European Journal of Endocrinology, BioScientifica, 2020, 183 (4), pp.369-379. ⟨10.1530/EJE-20-0054⟩
European Journal of Endocrinology, 2020, 183 (4), pp.369-379. ⟨10.1530/EJE-20-0054⟩
European Journal of Endocrinology, BioScientifica, 2020, 183 (4), pp.369-379. ⟨10.1530/EJE-20-0054⟩
European Journal of Endocrinology, 2020, 183 (4), pp.369-379. ⟨10.1530/EJE-20-0054⟩
Background: The ‘3PAs’ syndrome, associating pituitary adenoma (PA) and pheochromocytoma/paraganglioma (PPGL), is sometimes associated with mutations in PPGL-predisposing genes, such as SDHx or MAX. In ’3PAs’ syndrome, PAs can occur before PP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95d571a5c210b78b05504cc8ae8ad278
https://hal-amu.archives-ouvertes.fr/hal-03223143/document
https://hal-amu.archives-ouvertes.fr/hal-03223143/document
Autor:
Sébastien Boissonneau, Pauline Romanet, Emeline Tabouret, Olivier Chinot, Grégory Mougel, Noémie Basset, Dominique Figarella-Branger, Chantal Campello, Stéphane Fuentes, Anne Barlier, Kaissar Farah, Mikael Meyer, Catherine Roche, Romain Appay, Thomas Graillon, Henry Dufour
Publikováno v:
Neuro-Oncology Advances
Neuro-Oncology Advances, 2020, 2 (1), pp.vdaa068. ⟨10.1093/noajnl/vdaa068⟩
Neuro-oncology Advances
Neuro-Oncology Advances, 2020, 2 (1), pp.vdaa068. ⟨10.1093/noajnl/vdaa068⟩
Neuro-oncology Advances
International audience; Recent discoveries of multiple driver mutations open promising perspectives for targeted therapies in meningioma. Nevertheless, iterative recurrences of most aggressive meningiomas as extended skull base meningiomas are not sy
Autor:
Alexis Lebreton, Grégory Mougel
Publikováno v:
Espaces et sociétés. :57-73
Cet article propose, dans une perspective comparative, une lecture des processus de gentrification dans les villes de Londres et Berlin. Il s’agit de confronter l’aspect « universel » de la gentrification avec la singularite des contextes urbai